摘要:
The invention relates to a crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S) -tetrahydrofuran-3-yloxy)-benzyl]-benzene, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments.
摘要:
The invention relates to a crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments.
摘要:
The invention relates to crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments.
摘要:
The invention relates to crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments.
摘要:
Within the scope of the method for management and/or administration of access authorizations in a network, especially of access authorizations for internet and/or network main portals, the user administration is designed as a standardized, web protected and a decentralized process. For each main portal, a separate application is required and it is made possible for the user to seek possible internet and/or network main portals.
摘要:
Within the scope of the method for management and/or administration of access authorizations in a network, especially of access authorizations for internet and/or network main portals, the user administration is designed as a standardized, web protected and a decentralized process. For each main portal, a separate application is required and it is made possible for the user to seek possible internet and/or network main portals.